Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H. 1995

J D Isaacs, and G Hale, and H Waldmann, and A D Dick, and R Haynes, and J V Forrester, and P Watson, and P A Meyer

UI MeSH Term Description Entries
D008297 Male Males
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D014792 Visual Acuity Clarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast. Acuities, Visual,Acuity, Visual,Visual Acuities
D015864 Panuveitis Inflammation in which both the anterior and posterior segments of the uvea are involved and a specific focus is not apparent. It is often severe and extensive and a serious threat to vision. Causes include systemic diseases such as tuberculosis, sarcoidosis, and syphilis, as well as malignancies. The intermediate segment of the eye is not involved.

Related Publications

J D Isaacs, and G Hale, and H Waldmann, and A D Dick, and R Haynes, and J V Forrester, and P Watson, and P A Meyer
November 2000, Current opinion in oncology,
J D Isaacs, and G Hale, and H Waldmann, and A D Dick, and R Haynes, and J V Forrester, and P Watson, and P A Meyer
January 2001, Medical oncology (Northwood, London, England),
J D Isaacs, and G Hale, and H Waldmann, and A D Dick, and R Haynes, and J V Forrester, and P Watson, and P A Meyer
April 1993, Lancet (London, England),
J D Isaacs, and G Hale, and H Waldmann, and A D Dick, and R Haynes, and J V Forrester, and P Watson, and P A Meyer
March 1995, Analytical chemistry,
J D Isaacs, and G Hale, and H Waldmann, and A D Dick, and R Haynes, and J V Forrester, and P Watson, and P A Meyer
July 1997, Ugeskrift for laeger,
J D Isaacs, and G Hale, and H Waldmann, and A D Dick, and R Haynes, and J V Forrester, and P Watson, and P A Meyer
April 1996, British journal of haematology,
J D Isaacs, and G Hale, and H Waldmann, and A D Dick, and R Haynes, and J V Forrester, and P Watson, and P A Meyer
December 1988, Lancet (London, England),
J D Isaacs, and G Hale, and H Waldmann, and A D Dick, and R Haynes, and J V Forrester, and P Watson, and P A Meyer
May 1988, Bone marrow transplantation,
J D Isaacs, and G Hale, and H Waldmann, and A D Dick, and R Haynes, and J V Forrester, and P Watson, and P A Meyer
August 1991, Transplantation proceedings,
J D Isaacs, and G Hale, and H Waldmann, and A D Dick, and R Haynes, and J V Forrester, and P Watson, and P A Meyer
January 2000, Cytotherapy,
Copied contents to your clipboard!